Jane Street
APRE icon

Jane Street’s Aprea Therapeutics APRE Stock Holding History

Jane Street’s Portfolio APRE Stock Details APRE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-605
Closed -$62K – 10006
2021
Q3 		$62K Buy
+605
New +$55K ﹤0.01% 9476

Other funds holding APRE

ACM
AIGH Capital Management Baltimore, Maryland $992M AUM 516.32% 1-Year Est. Return
Nantahala Capital Management
Nantahala Capital Management New Canaan, Connecticut $3.16B AUM 31.44% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $73.4B AUM 32.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $294B AUM 47.59% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $463B AUM
Morgan Stanley
Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return
HRT Financial
HRT Financial New York $57.2B AUM 52.85% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $468B AUM 17.69% 1-Year Est. Return

Jane Street's APRE Position: Q3 2026 in Review

Jane Street opened a new position in Aprea Therapeutics (APRE) in Q3 2026: 13,882 shares worth $10.4K. The stake represents ﹤0.01% of the portfolio and ranks #11410 among its holdings. This is a return to the name: Jane Street previously reported a position in APRE as recently as Q4 2025.

Jane Street first reported a position in APRE in Q4 2020 and has held it in 7 quarters since. The position peaked at $72K in Q3 2021. 19 funds tracked by Wall St. Rank hold APRE as of Q3 2026.

  • Jane Street held 13,882 shares of Aprea Therapeutics worth $10.4K as of Q3 2026.
  • Aprea Therapeutics was a new Jane Street position in Q3 2026.
  • Aprea Therapeutics made up ﹤0.01% of Jane Street's portfolio in Q3 2026, its #11410 holding.
  • Jane Street first reported a position in Aprea Therapeutics in Q4 2020 and has held it in 7 quarters since.
  • Jane Street's Aprea Therapeutics position peaked at $72K in Q3 2021.
  • 19 funds tracked by Wall St. Rank held Aprea Therapeutics as of Q3 2026.

Based on Jane Street's 13F filing for Q3 2026, filed 12 Nov 2026.